DHR — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Danaher Corporation
Healthcare · $191.12
1.0
/10
Avoid
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-8.9%
Below trend
Volatility
Normal
Average premiums
Momentum
Accelerating
Price direction
About Danaher Corporation
Danaher sells bioprocessing equipment, diagnostics instruments, and life sciences consumables (Cytiva, Beckman Coulter, Pall brands). Beta ~1.0, tiny ~0.5% yield. Low-volatility compounder — premiums are thin. Biotech funding cycles and M&A announcements can generate occasional 5–8% moves worth watching for put-selling entries.
Life Sciences Tools & Services
Market Cap
$135.3B
P/E Ratio
38.0
Dividend
84.00%
Beta
0.99
52-Week Range Current: $191.12
$171 $242.8
Earnings
2026-04-21
16 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE